Anthropic's Claude 4 family scores above GPT-4o on GPQA Diamond (65.0 vs 53.6 as of the April 2026 model card) and John Jumper, the AlphaFold 2 lead and 2024 Nobel laureate in chemistry, joined the lab's research division this month. The Trump administration's export controls, reported by Ars Technica on June 23, restrict Anthropic API access for entities in BIS Entity List jurisdictions and require end-use certification for Singapore, South Korea, and Japan -- the three nodes through which Anthropic's APAC enterprise contracts currently route.

The controls do not touch model weights. They gate the deployment surface: the AWS Singapore region (ap-southeast-1) and the Azure Japan East region (japaneast) that carry Anthropic's Claude API traffic to APAC enterprise customers now require BIS-compliant end-use documentation before activation, a compliance layer that adds four to eight weeks to enterprise onboarding cycles. Jumper's arrival compounds the irony -- the lab's protein-structure research program, which is the specific capability set that makes Claude relevant to Japanese pharmaceutical and South Korean biotech enterprise customers, deepens at the same moment the certification window closes. Anthropic's Q3 2026 APAC pipeline, per industry reporting, sits at approximately 340 enterprise contract initiations; the BIS certification backlog as of June 20 was processing at 60 cases per week.